PRESS RELEASE published on 11/08/2023 at 14:30, 2 years 7 months ago Jaguar Health to Hold Investor Webcast Tuesday, November 14th at 8:30 AM Eastern Regarding Q3 2023 Financials & Corporate Updates
PRESS RELEASE published on 11/07/2023 at 14:30, 2 years 7 months ago REMINDER: Jaguar Health to Host Virtual Educational Webinar on Rare Intestinal Failure Diseases with Leading Gastroenterologists and Nutrition Experts November 8th from 1:00 PM to 2:30 PM EST
PRESS RELEASE published on 11/02/2023 at 13:30, 2 years 7 months ago Jaguar Health Enters Exclusive Crofelemer Revenue Sharing License and Commercialization Agreement with Quadri Pharmaceuticals Store for Rare Intestinal Failure Diseases in Middle East Markets
PRESS RELEASE published on 11/01/2023 at 13:30, 2 years 7 months ago Issuance of New US Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
PRESS RELEASE published on 10/30/2023 at 13:30, 2 years 7 months ago Magdalena Biosciences, a Joint Venture between Jaguar Health and Filament Health, Receives Second Tranche of Funding from One Small Planet
PRESS RELEASE published on 10/26/2023 at 14:30, 2 years 7 months ago Jaguar Health to Present November 1st at Emerging Growth Conference
PRESS RELEASE published on 10/23/2023 at 14:30, 2 years 8 months ago Magdalena Biosciences Initiates Preclinical Study to Evaluate Plant Extracts to Treat Depression, Anxiety, ADHD and Other Mental Health Indications
PRESS RELEASE published on 10/19/2023 at 14:30, 2 years 8 months ago Independent Study Conducted at Boston Children's Hospital, Harvard Medical School, Shows Potential Utility of Jaguar Health's Crofelemer for Treatment of MVID, a Rare Childhood Disease
PRESS RELEASE published on 10/18/2023 at 14:30, 2 years 8 months ago Napo Pharmaceuticals to Exhibit at the October 25-28 Annual Association of Nurses in AIDS Care (ANAC) Conference for Mytesi, the Company’s FDA-Approved Prescription Drug
PRESS RELEASE published on 10/12/2023 at 14:30, 2 years 8 months ago Jaguar Health to Present October 17 at the Lytham Partners Fall 2023 Investor Conference and October 18 at the BIO Investor Forum
Published on 06/26/2026 at 01:40, 8 hours 18 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 10 hours 28 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 11 hours 28 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 12 hours 26 minutes ago BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 18 hours 28 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/26/2026 at 09:43, 14 minutes ago ABO Energy secures wind energy tariffs and achieves further successes
Published on 06/26/2026 at 09:41, 17 minutes ago Emerald Horizon AG begins trading on the Vienna Stock Exchange
Published on 06/26/2026 at 09:26, 32 minutes ago Hamburg Direct Bank wins two German Brand Awards 2026
Published on 06/26/2026 at 09:25, 33 minutes ago SKYWORTH Solar Shines at Intersolar Europe 2026, Shaping the Future of Energy in Europe with a Comprehensive Product Matrix
Published on 06/26/2026 at 09:19, 38 minutes ago Zero Waste Foundation brought Türkiye’s COP31 vision to Bonn
Published on 06/26/2026 at 07:00, 2 hours 58 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 2 hours 58 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 15 hours 13 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 15 hours 28 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 16 hours 8 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
